Skip to main content
Premium Trial:

Request an Annual Quote

Exelixis Offers 10 Million Shares at $7.10 Each

NEW YORK, June 20 - Exelixis said today that it will offer 10 million shares of its common stock at $7.10 per share.

 

The South San Francisco-based company expects to earn approximately $66.3 million in net proceeds from the offering. Underwriters will have the option to purchase up to an additional 1.5 million shares of common stock.

 

Exelixis' common stock was trading at about $7.30 this morning.

 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.